IS7202A
Combinations for the treatment of immunoinflammatory disorders
Abstract
The invention features, among others, a medicament comprising (i) a corticosteroid, and (ii) a tetra-substituted pyrimidopyrimidine, as well as its use in a method of treating a patient who has an immunoinflammatory disorder or is at risk for developing an immunoinflammatory disorder.
Term
Term ended
Projected expiry passed 31 March 2024, 2.5 years ago.
- Priority
- Filed and published
- Projected expiry
- Today
7 priority claims, no other members on record
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 32767401 | United States of America | P | |
| 32767401 | United States of America | P | |
| 0231866 | United States of America | W | |
| 0231866 | United States of America | W | |
| PCTUS0231866 | – | – | – |
| US20010327674P | – | – | – |
| WO2002US31866 | – | – | – |
Numbers
- Publication, DOCDB
- 7202
- Publication, EPODOC
- IS7202
- Application
- 7202
- Application, DOCDB
- 7202
- Application, EPODOC
- IS20040007202
Titles2
- Icelandic
- Samsetningar til meðhöndlunar á ónæmisbólgusjúkdómum
- English
- Compositions for the treatment of immunosuppressive diseases
Classification
- CPC, 19
- A61K45/06
- A61K31/519
- A61K31/56
- A61K31/573
- A61K31/675
- A61P1/00
- A61P1/04
- A61P3/10
- A61P11/06
- A61P17/00
- A61P17/06
- A61P19/02
- A61P21/00
- A61P25/00
- A61P29/00
- A61P37/00
- A61P37/02
- A61P37/06
- A61P43/00
- IPC, 18
- A61K
- A61K31 519
- A61K31 56
- A61K31 57
- A61K31 573
- A61K31 675
- A61K45 06
- A61P1 04
- A61P3 10
- A61P11 06
- A61P17 00
- A61P17 06
- A61P19 02
- A61P21 00
- A61P25 00
- A61P29 00
- A61P37 02
- A61P43 00